Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome: Implications for Therapy

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.4, Iss.2, 2004-01, pp. : 93-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association Between Polycystic Ovary Syndrome and Metabolic Syndrome

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-11 ,pp. : 3999-4012

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic contributions to glucose intolerance in polycystic ovary syndrome

By Ehrmann David A

Reproductive BioMedicine Online, Vol. 9, Iss. 1, 2004-07 ,pp. : 28-34

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment

By Garruti Gabriella Depalo Raffaella Vita Maria Grazia Lorusso Filomenamila Giampetruzzi Federica Damato Aurelia Bellomo Giorgino Francesco

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 552-563

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Polycystic ovary syndrome

By Franks Stephen

Clinical Medicine, Vol. 32, Iss. 2, 1998-03 ,pp. : 111-113

Royal College Of Physicians

Access to resources Recommend Favorite

Metabolic Basis of Polycystic Ovarian Syndrome; Indications for Biochemical Screening

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. : 61-71

Bentham Science Publishers

Access to resources Recommend Favorite